• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

ISS biased with former employee now with Pershing.

Anonymous

Guest
Pershing hired Credit Suisse to help with Allergan takeover...and according to NYT "That defense unit at Credit Siusse is headed by Chris Young, who formerly led mergers and proxy fight research at Institutional Shareholder Services, the influential proxy adviser."
 

<











they dont need former employees to be biased. their revenue stream is shareholdr services ... this type of stuff keeps their lights on


thats why this news was only relevant for 1 hour